Patent classifications
A61B2018/00255
CRYOABLATION CATHETER
A cryoablation catheter, comprising a balloon (1) and a delivery catheter (2) passing through the balloon (1). The delivery catheter (2) is provided with a fluid inflow cavity (21) and a fluid outflow cavity (22) therein. The fluid inflow cavity (21) extends into the balloon (1), and a side wall of the fluid inflow cavity (21) is provided with a spray head (211) that injects a liquid into the balloon (1). The spray head (211) has a number of spray holes (2111, 2112) circumferentially arranged on the exterior of the fluid inflow cavity (21). An end of the fluid outflow cavity (22) has a cross section (24) that seals the fluid outflow cavity (22), and a side wall of the fluid outflow cavity (22) is provided with a reflow hole (221) in communication with the balloon (1). A fluid flows from the fluid inflow cavity (21) through the nozzle holes (2111, 2112) into the balloon (1). The nozzle holes (2111, 2112) are evenly distributed outside the fluid inflow cavity (21), so that the interior of the balloon (1) is uniformly filled with the refrigeration fluid, ensuring the uniformity of heat exchange at each part of the balloon (1) in an axial direction. The fluid then flows out from the reflow hole (221). The structural design can effectively improve the heat exchange efficiency of the fluid, and the production and processing processes are relatively simple.
HEMOSTASIS METHODS AND APPARATUSES
A probe is configured with a flushing port and an evacuation port to establish a flow path to remove blood from a resected tissue. The probe comprises a balloon configured to expand and contact the resected tissue to compress filaments and improve access to the underlying blood vessels for coagulation with an energy source. An endoscope can be used to view the tissue, and the balloon may comprise a transparent material or a viewing port to allow imaging of the bleeding tissue through the balloon. The probe may have a light source to illuminate the tissue with a beam oriented at an oblique angle to the tissue surface, which can decrease interference from blood and may allow more localized coagulation of the blood vessel.
MRI-compatible cryocatheters and system
A system and device for cryoablation of tissue that is suitable for use within an MRI environment. The device may include an elongate body, a treatment element at the distal portion of the elongate body, and one or more pull fibers. The pull fibers may be composed of a non-ferromagnetic material, such as a polymer. Likewise, none of the other device components may be composed of a ferromagnetic material. The device may also include at least one fiber optic sensor. The elongate body distal portion may include a distal tip to which the pull fibers are directly coupled. Additionally or alternatively, the elongate body may include one or more pull fiber lumens configured to allow the pull fibers to deflect the distal portion when a pull force is exerted on the pull fibers.
Cryogenic balloon device with radiofrequency treatment region
An intravascular ablation device, including a flexible elongate body; an expandable element positioned on the elongate body; a radiofrequency or electroporation treatment segment located distally of the expandable element; a cryogenic coolant source in fluid communication with an interior of the expandable element; and a radiofrequency or electroporation energy source in communication with the radiofrequency or electroporation treatment segment.
Devices for therapeutic nasal neuromodulation and associated methods and systems
A device for therapeutic neuromodulation in a nasal region can include, for example, a shaft and a therapeutic element at a distal portion of the shaft. The shaft can locate the distal portion intraluminally at a target site inferior to a patient's sphenopalatine foramen. The therapeutic element can include an energy delivery element configured to therapeutically modulate postganglionic parasympathetic nerves at microforamina of a palatine bone of the human patient for the treatment of rhinitis or other indications. In other embodiments, the therapeutic element can be configured to therapeutically modulate nerves that innervate the frontal, ethmoidal, sphenoidal, and maxillary sinuses for the treatment of chronic sinusitis.
SYSTEM AND METHOD FOR MAINTAINING BALLOON INTEGRITY WITHIN INTRAVASCULAR LITHOTRIPSY DEVICE WITH PLASMA GENERATOR
A catheter system (100) for treating a treatment site (106) includes an energy source (124), a balloon (104), an energy guide (122A), and a balloon integrity protection system (142). The energy source (124) generates pulses of energy. The balloon (104) is positionable substantially adjacent to the treatment site (106). The balloon (104) has a balloon wall (130) that defines a balloon interior (146). The balloon (104) is configured to retain a balloon fluid (132) within the balloon interior (146). The energy guide (122A) is configured to receive the energy from the energy source (124) and guide the energy into the balloon interior (146) so that plasma is formed in the balloon fluid (132) within the balloon interior (146). The balloon integrity protection system (142) is operatively coupled to the balloon (104). The balloon integrity protection system (142) is configured to inhibit temperature-induced rupture of the balloon (104) due to the plasma formed in the balloon fluid (132) within the balloon interior (146) during use of the catheter system (100).
BALLOON CATHETER
A balloon catheter includes a catheter (1) and a balloon body (2) sleeved on the catheter (1). The balloon body (2) includes an inner layer balloon (21) and an outer layer balloon (22). The inner layer balloon (21) and the outer layer balloon (22) are both directly wrapped and fixed on the catheter (1). The inner layer balloon (21) is located inside the outer layer balloon (22). A medium channel (23) is formed between the inner layer balloon (21) and the outer layer balloon (22). An outer layer medium inlet hole (11) and a medium backflow hole (12) both in communication with the medium channel (23) are provided in the catheter (1). In the balloon catheter, the double-layer balloon body (2) is provided, so that a medium can flow in the medium channel (23) between the inner layer balloon (21) and the outer layer balloon (22), the medium flows into the medium channel (23) through the outer layer medium inlet hole (11), and then the medium in the medium channel (23) flows out through the medium backflow hole (12) to implement circulation. In this way, more medium can exchange heat on the inner surface of the outer layer balloon (22) and the flow rate distribution is relatively uniform, to increase the flowing quality of the medium on the surface of the balloon body, thereby improving the heat exchange efficiency.
Esophageal ablation technology
An esophageal ablation system including a positioner, an elongated, flexible shaft extending from the positioner, and a microwave emitter, assembly disposed near the distal end of the shaft. The emitter assembly includes one or more microwave antennas and a balloon for spacing the antennas relative to target tissue. The device may have an inner balloon for deploying the antenna. The systems, devices and methods disclosed are useful for treating Barrett's Esophagus, Esophageal Adenocarcinoma, and Squamous Cell Carcinoma.
Multi-electrode balloon catheter with circumferential and point electrodes
A catheter has a balloon electrode assembly with at least one compliant balloon member and at least one electrode carried on an outer surface of the balloon member for accomplishing circumferential sensing or ablation in a tubular region of the heart, including a pulmonary vein or ostium. The catheter may also include an electrode assembly with a tip and/or ring electrode distal of the balloon electrode assembly adapted for focal contact.
ESOPHAGEAL ABLATION TECHNOLOGY
An esophageal ablation system including a positioner, an elongated, flexible shaft extending from the positioner, and a microwave emitter assembly disposed near the distal end of the shaft. The emitter assembly includes one or more microwave antennae and a balloon tor spacing the antennae relative to target tissue. The device may have an inner balloon for deploying the antenna. The systems, devices and methods disclosed are useful for treating Barrett's Esophagus, Esophageal Adenocarcinoma, and Squamous Cell Carcinoma.